Trial
NCT01504477
Panitumumab and Bortezomib for Patients With Advanced Colorectal Cancer
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Georgetown University
Collaborators
Millennium Pharmaceuticals, Inc.
Condition
Colorectal Cancer
Intervention
Panitumumab and bortezomib
Why stopped
Low accrual--unable to meet accrual goals
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-03-16